Updated 13 May 2014
Round Table sessions will be held on Thursday 12 June and Friday 13 June 2014 - 07:15-08:15
| Category | 12 June 2014 | 13 June 2014 |
| Clinical Trials/New Therapies | ENaC an underestimated therapeutic target Leader: Marcus Mall, DE |
|
| ICM measurements and organoids: complementary or not? Leader: Nico Derichs, DE |
||
| Microbiology/Antibiotics | Sinus infection and the CF lung Leader: Helle Krogh Johansen, DK |
Update on infection with Achromobacter spp. in CF Leader: Niels Norskov-Lauritsen, DK |
|
Infection control - multiple pathogens and multiple practical issues |
Update on Staphylococcus aureusinfection in CF Leader: Damian Downey, UK |
|
| Nursing/Psychosocial Issues | Late diagnosis Leader: Kristine Colpaert, BE |
Travelling with CF Leader: A.Peres, UK |
| Physiotherapy |
Supplemental Oxygen on Exertion: The practicalities and recommendations |
GOR and physiotherapy interventions Leader: Brenda Button, AU |
| Managing the Intubated CF Patient Leader: Louise Lannefors, SE |
Exericse - The Scandinavian Approach Leader: Margareta Sahlberg, SE |
|
| Pulmonology/Immunology/ Inflammation | Fungal infection in CF Leader: Andrew Jones, UK |
Quality Improvement-based clinical interventions in CF Leader: Michael Boyle, US |
| Atypical CF - investigation and management including labels Leader: Kris De Boeck, BE |
||
| Eradication of bacteria in adults with CF Leader: Harry Heijerman, NL |
||
| Genetics/Screening/Diagnosis | How to communicate newborn screening results to families Leader: Mandy Bryon, UK |
How to establish newborn screening in your country Leader: Kevin Southern, UK |
| Registry/Epidemiology | Survival analyses using registries Leader: Virginie Scotet, FR |
Which patients to enter in the Registry. How to define? Leader: Muriel Thomas, BE |
| GI/Nutrition/Liver Disease/ Metabolic Complications |
Enteral tube feeding and impact Leader: Susannah King, AU |